Tejara Capital LTD Cardiol Therapeutics Inc. Transaction History
Tejara Capital LTD
- $216 Billion
- Q2 2025
A detailed history of Tejara Capital LTD transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 3,265,819 shares of CRDL stock, worth $3.56 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
3,265,819
Previous 3,194,990
2.22%
Holding current value
$3.56 Million
Previous $3.1 Billion
43.34%
% of portfolio
2.06%
Previous 1.2%
Shares
10 transactions
Others Institutions Holding CRDL
# of Institutions
42Shares Held
6.71MCall Options Held
37.6KPut Options Held
0-
Advisor Shares Investments LLC Bethesda, MD857KShares$934,5520.22% of portfolio
-
Lion Street Advisors, LLC340KShares$370,6270.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$319,4310.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$308,9841.46% of portfolio
-
Cambridge Investment Research Advisors, Inc.206KShares$224,8280.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $67.5M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...